Skip to main navigation Skip to search Skip to main content

Similar biological activities of two isostructural ruthenium and osmium complexes

  • Jasna Maksimoska
  • , Douglas S. Williams
  • , G. Ekin Atilla-Gokcumen
  • , Keiran S.M. Smalley
  • , Patrick J. Carroll
  • , Richard D. Webster
  • , Panagis Filippakopoulos
  • , Stefan Knapp
  • , Meenhard Herlyn
  • , Eric Meggers
  • University of Pennsylvania
  • Wistar Institute
  • Nanyang Technological University
  • University of Oxford
  • University of Marburg

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Abstract

In this study, we probe and verify the concept of designing unreactive bioactive metal complexes, in which the metal possesses a purely structural function, by investigating the consequences of replacing ruthenium in a bioactive half-sandwich kinase inhibitor scaffold by its heavier congener osmium. The two isostructural complexes are compared with respect to their anticancer properties in 1205 Lu melanoma cells, activation of the Wnt signaling pathway, IC50 values against the protein kinases GSK-3β and Pim-1, and binding modes to the protein kinase Pim-1 by protein crystallography. It was found that the two congeners display almost indistinguishable biological activities, which can be explained by their nearly identical three-dimensional structures and their identical mode of action as protein kinase inhibitors. This is a unique example in which the replacement of a metal in an anticancer scaffold by its heavier homologue does not alter its biological activity.

Original languageEnglish
Pages (from-to)4816-4822
Number of pages7
JournalChemistry - A European Journal
Volume14
Issue number16
DOIs
StatePublished - May 29 2008

Keywords

  • Antitumor agents
  • Bioorganometallic chemistry
  • Kinase inhibitors
  • Osmium
  • Ruthenium

Fingerprint

Dive into the research topics of 'Similar biological activities of two isostructural ruthenium and osmium complexes'. Together they form a unique fingerprint.

Cite this